Kanak R Patel, MD Internal Medicine - Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 2001 Medical Parkway, Acute Care Pavilion, Annapolis, MD 21401 Phone: 443-481-1000 Fax: 443-481-1687 |
Dr. Steven C Resnick, MD Internal Medicine - Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 2000 Medical Pkwy, Suite 607, Annapolis, MD 21401 Phone: 410-266-1644 Fax: 410-266-1642 |
Dr. Howard S Young, MD Internal Medicine - Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 2000 Medical Pkwy, Suite 607, Annapolis, MD 21401 Phone: 410-266-1644 Fax: 410-266-1642 |
Dennis Frank, M.D. Internal Medicine - Critical Care Medicine Medicare: Not Enrolled in Medicare Practice Location: 6 Southgate Ave, Annapolis, MD 21401 Phone: 301-980-2077 |
Christopher Barnett, PA Internal Medicine - Critical Care Medicine Medicare: Medicare Enrolled Practice Location: 214 Wesley Brown Ln, Annapolis, MD 21401 Phone: 443-844-9789 |
News Archive
Merck & Co., Inc. today announced financial results for the second quarter of 2010. The company reported non-GAAP (generally accepted accounting principles) earnings per share (EPS) for the second quarter of $0.86, which excludes purchase accounting adjustments, merger-related expenses, restructuring costs and the gain on AstraZeneca's asset option exercise. Second-quarter GAAP EPS was $0.24.
As the cholera outbreak continues to spread in the Artibonite region of Haiti, World Vision is increasing its response in affected areas, pre-positioning much-needed health supplies and preparing residents in its displacement camps in Port-au-Prince with critical, life-saving health and hygiene messages.
More than 50 Fortune 500 companies have joined forces to give an estimated four million uninsured working Americans access to affordable health insurance coverage. The united effort is part of a broad market reform to reduce spiraling health care costs and incorporate performance standards that help consumers choose hospitals and physicians.
ERYTECH Pharma, a French biopharmaceutical company that develops innovative treatments for acute leukemia and other oncology indications with unmet medical needs, announces that the ANSM, French healthcare agency, has granted the authorization to start a Phase II study in second line treatment of patients affected by pancreatic cancer.
› Verified 1 days ago